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LO-C.10 RECIPIENT OBESITY
ADVERSELY AFFECTS LONG-TERM
GRAFT AND OVERALL SURVIVAL IN A
SINGLE INSTITUTION ANALYSIS
K. D. Conzen1, N. Vachharajani1, K. M. Collins1,
C. D. Anderson2, Y. Lin1, J. R. Wellen1, S. Shenoy1,
J. A. Lowell1, M. Doyle1 and W. Chapman1
1Washington University In St. Louis, Department Of
Surgery, St. Louis, MO; 2University Of Mississippi Medical
Center, Department Of Surgery, Jackson, MS
Introduction: The effect of obesity in liver transplantation
remains controversial. Earlier data from our institution dem-
onstrated no significant difference in post-operative compli-
cations or one-year mortality. We hypothesized that obesity
alone has minimal effect on long-term graft and overall
survival.
Methods: A retrospective study of all primary orthotopic
liver transplants (OLT) at our center (1/1/2002–12/31/2012)
was conducted. OLT recipients were divided into six groups
based on pre-transplant BMI: Group 1 (BMI < 18), Group 2
(18–24.9), Group 3 (25–29.9), Group 4 (30–35), Group 5
(35.1–40) and Group 6 (>40). Pre- and post-transplant
parameters were compared between groups. Differences in
outcomes were determined using the log-rank test, Chi-
square test, and student’s t-test; p-value < 0.05 was consid-
ered significant.
Results: Seven hundred eighty-five patients met inclusion
criteria. Numbers of recipients in each group were: (group
1)9, (2)210, (3)294, (4)169, (5)77, (6)26. No differences
were observed in race, age, massive ascites, or diabetes.
Recipients with BMI >35 were more likely to have NASH
cirrhosis (p < 0.0001) and wait longer for transplant
(p = 0.002). There were no differences in operative time, ICU
LOS, hospital LOS, vascular thrombosis, bleeding, biliary
complications, or infection. Seven year graft survival (36.7%
vs 62–79%) and overall survival (38% vs 62–81%) were
significantly decreased for BMI >40 (p < .02).
Conclusion: Obesity increasingly impacts the field of liver
transplantation. Although limited by a single institution, our
data suggests that morbid obesity adversely affects long-term
outcomes despite similar short-term results. Further analysis
is indicated to identify risk factors for poor outcomes in
morbidly obese patients.
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OP-I.01 HIDA SCAN OF THE FLR IS
SUPERIOR TO VOLUMETRY TO ASSESS
LIVER FUNCTION IN ALPPS
E. Schadde1, M. Lesurtel1, N. Schäfer2 and P. Clavien1
1Dept. Of Visceral And Transplant Surgery, University Of
Zurich Hospital, Zurich, ZURICH; 2Dept. Of Nuclear
Medicine, University Of Zurich Hospital, Zurich, ZURICH
Introduction: ALPPS (Associating Liver Partition with
Portal vein ligation for Staged hepatecomy) induces rapid
hypertrophy, but the functionality of the tissue has been
questioned even when volume cut-offs of the future liver
remnants of 30% prior to resection are respected. 99m-
Technetium-mebrofenin clearance capacity of the future liver
remnant (FLR) of less than 1.8 %/min/BSA using HIDA
scintigraphy has been postulated to increase the risk of post-
operative liver failure after resection. We assessed the value
of HIDA in a pilot series of patients undergoing ALPPS and
Portal Vein Embolization (PVE).
Methods: Four patients undergoing ALPPS were compared
with 4 patients undergoing PVE before stage 1 and stage 2.
Scintigraphy was performed by intraveneous injection
80 MBq99m Technetium-mebrofenin. Dual head dynamic
acquisitions were used to calculate FLR function. MRI
volumetry was used to assess volume changes. Postoperative
liver failure was assessed using 50/50 criteria.
Results: One patient in the ALPPS group and one patient in
the PVE group developed fatal postoperative liver failure.
These two patients had a FLR function after hypertrophy of
only 2.14 (ALLPS) and 1.28 (PVE) %/min/BSA, despite
having reached a FLR volume of greater than 30%. In con-
trast the FLR function of patients with an uncomplicated
postoperative course was 3.6, 5.5 and 4.6 %/min/BSA in the
ALPPS group and 2.3, 3.7 and 5.4 %/min/BSA in the PVE
group.
Conclusion: In ALPPS and also PVE, assessment of FLR
function using 99m Technetium-mebrofenin clearance capac-
ity of the future liver remnant is superior to volumetry to
assess resectibility.
OP-I.02 MORBIDITY AND MORTALITY
IN 1174 PATIENTS UNDERGOING
HEPATIC PARENCHYMAL
TRANSECTION USING A STAPLER
DEVICE
M. Raoof2, T. A. Aloia1, J. Vauthey1 and S. A. Curley1
1University Of Texas, MD Anderson Cancer Center,
Houston, TX; 2University Of Arizona, Tucson, AZ
Background: Transection of liver parenchyma using sta-
plers is now commonly performed. Large studies are needed
to assess the usefulness of the technique as well as peri-
operative outcomes.
20 Abstracts
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 1), 1–99
Methods: This is a retrospective study of a prospectively
maintained database. A total of 1174 patients undergoing
liver resections in routine surgical practice, using a stapler
device at our Cancer Center between January 1, 1994 and
November 10, 2011 were evaluated.
Results: There were 900 (77%) major resections (3 seg-
ments or more) and 274 (23%) minor resections (<3 seg-
ments or wedge resections). A vast majority, 1133 (96.5%)
were indicated for an underlying malignancy (24% primary
liver or gall bladder and 72.5% metastatic) compared to
benign disease 41 (3.5%), with the most common indication
being metastatic colorectal cancer 584 (49.7%). Of the total
1174 patients 128(10.9%) had a prior liver resection. Median
OR time and blood loss was 206 min and 300 ml, respec-
tively, with 11% of patients requiring transfusion in the peri-
or post-operative period. Overall-morbidity and mortality
rate was 14% and 3.2%, respectively, with a median hospital
stay of 7 days (IQR 4). Multivariate logistic regression dem-
onstrated blood loss and extent of liver resection to be inde-
pendent predictors of adverse outcome. Thirteen instances
(1.1%) of misfired staplers were noted and were associated
with higher blood loss (p < 0.001) and mortality (15% vs.
3.1%, p = 0.013).
Conclusion: Use of stapler device for hepatic resection is
safe and effective but rare instances of a misfired stapler
device are associated with an adverse outcome.
OP-I.03 MRI WITH GADOXETATE
DISODIUM FOR COLORECTAL LIVER
METASTASIS: IS IT THE NEW GOLD
STANDARD?
S. Patel, S. Cheek, H. Osman, T. Winston and D. Jeyarajah
Methodist Dallas Medical , Dallas, TX
Background: Approximately 15–45% of patients develop
hepatic metastasis from colorectal cancers (CRLM) within 3
years of diagnosis. Accurate detection of CRLM is para-
mount in the role of hepatectomy. This study aims to
compare Magnetic Resonance Imaging (MRI) with
gadoxetate disodium (Eovist) to enhanced Computed
Tomography (CT) in detecting CRLM.
Methods: A retrospective chart analysis of 30 patients from
2011–2013 with CRLM was performed. Patients with more
than 6 weeks or 2 cycles of chemotherapy between the two
imaging modalities were excluded. The number of lesions
identified on enhanced CT vs. MRI with Eovist was
compared.
Results: A total of 30 patients underwent enhanced CT
scans initially then subsequently evaluated with MRI with
Eovist. 12 (40%) patients had more lesions identified on MRI
with Eovist. 18(60%) had no change in the number of lesions
identified. All lesions identified on CT were evident on MRI.
When MRI with Eovist detected more lesions, the mean
number of additional lesions detected was 1.5 (1–4).
Conclusion: MRI with gadoxetate disodium (Eovist) is
superior to enhanced CT in identifying CRLM. The
increased number of lesion identified on MRI with Eovist can
profoundly change the surgeon’s management. It should be
considered the “gold standard” in pre-operative imaging for
liver metastasis in these patients.
OP-I.04 RACIAL DISPARITY OUTCOMES
IN PATIENTS UNDERGOING
HEPATECTOMY: IS RENAL FUNCTION
THE DRIVING FORCE?
J. E. Dowden, D. J. Taber, J. W. McGillicuddy, C. Bratton,
P. Baliga and K. D. Chavin
Medical University Of South Carolina, Division Of
Transplant Surgery, Charleston, SC
Objective(s): The aim of this study was to determine if
African-Americans (AA) undergoing hepatic resection
experience differences in surgical outcomes and conduct
modeling to develop potential mechanisms that help to
explain this disparity.
Methods: This was an observational longitudinal cohort
study. Comprehensive baseline and clinical data was col-
lected from medical records in patients undergoing partial
hepatectomy from 2004–2012. Both open and laparoscopic
procedures were included; pediatric patients were excluded.
Analysis included univariate and multivariate statistics.
Results: 166 patients (59 AA, 107 non-AA) underwent
partial hepatectomy and were included. AA patients were
more likely to be female, have a higher BMI, have resections
due to hemangiomas or adenomas, and have steatosis on
explant analysis. Intra-operatively, AA patients had longer
surgeries, more blood loss and higher blood product utiliza-
tion. Significant post-operative complications were signifi-
cantly more common in AA patients. Multivariable modeling
demonstrated that race, history of Hepatitis C and EBL were
the only variables that were independently associated with a
major post-operative complication; however, baseline serum
creatinine was the only variable that significantly modified
the effect of race on complications. AAs with normal SrCr
levels had similar rates of complications, but as the baseline
SrCr level increased, the odds-ratio of developing a compli-
cation for AA patients dramatically increased (Figure 1).
Conclusions: AA patients have longer and more complex
hepatectomy surgeries and experience a higher rate of major
post-operative complications, which is predominantly driven
by a subset of highly vulnerable AA patients that have pre-
existing renal insufficiency.
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OP-I.05 IMPACT OF NEO-ADJUVANT
CHEMOTHERAPY ON PARENCHYMAL
SPARING IN HEPATECTOMY FOR
COLORECTAL LIVER METASTASIS
S. Kaihara, K. Okada, K. Inoguchi, S. Yo, T. Yamamoto,
S. Yagi, K. Uryuhara and R. Hosotani
Kobe City Medical Center General Hospital, Kobe,
HYOGO
Object: One of the aims of neo-adjuvant Chemotherapy
(NAC) for colorectal liver metastasis (CRLM) is to increase
rate of margin negative and preserve the hepatic parenchyma
in hepatectomy. In this study we focused on the effect of
NAC on parenchymal sparing in hepatectomy for CRLM
with analyzing the change of tumor size and relationship
with the intrahepatic vessels.
Methods: Forty tumors in 20 patients who received NAC
before hepatectomy for CRLM were evaluated in this study.
The change of maximal tumor size and distance from major
intrahepatic vessels were measured before and after NAC.
Results: The maximal tumor size before and after NAC was
44.8 +/− 41.9 mm and 34.3 +/− 34.3 mm and the tumor size
decreased 20.6 +/− 29.8%. The distance between the center
of the tumors to the vessels before and after NAC were
23.8 +/− 20.3 mm and 16.9 +/− 14.5 mm and the distance
decreased 28.7 +/− 13.9%. However, the space between the
edge of the tumor and the vessels did not change (before and
after NAC were 0.6 +/− 1.3 mm and 1.1 +/− 2.6 mm). After
NAC, operation mode was changed to spare the hepatic
parenchyma in 7 patients.
Summary: NAC induced the tumor downsizing; however,
the space between the tumor and the vessel did not change.
These results indicated that the adjacent vessels to the tumor
should be resected to achieve R0 resection and the parenchy-
mal sparing was not achieved by preserving intrahepatic
vessels but only by tumor downsizing after NAC for CRLM.
OP-I.06 FALLING BARRIERS TO
LAPAROSCOPIC LIVER RESECTION
A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil and
J. Buell
Tulane Transplant Institute, New Orleans, LA
Introduction: Laparoscopic liver resection is an accepted
modality for the management of a variety of benign and
malignant tumors. Initial efforts were focused on peripheral
lesions. We now examine selected patient demographics and
extent of operative interventions that might have previously
precluded a laparoscopic approach.
Methods: Retrospective review of 615 patients managed by
a single surgeon from 2000 to 2013. Analysis was performed
to compare and contrast demographics and operative charac-
teristics between both open and laparoscopic hepatic
resections.
Results: 753 hepatic resections in 615 patients were
reviewed. Demographics (age, BMI, incidence of cancer and
cirrhosis) were compared between open and laparoscopic
approaches and found to be equivalent. In contrast ASA was
higher in the open group (3.0 vs. 3.1:p < 0.05) as was the
extent of resection as indicated by number of segments
resected (3.0 vs. 2.4:p < 0.001) and percentage of major
resections (formal lobe) (23.3 vs. 47.0:p < 0.001).
Conclusion: This analysis identified few patient demo-
graphics as continued barriers to a laparoscopic approach.
Initial analysis does confirm open surgical techniques are
reserved for patients deemed more critically ill, using ASA as
a surrogate marker. The incidence of formal lobar resection
was also significantly different indicating large atypical
resections are most often reserved for an open approach. This
study demonstrates that some barriers to a laparoscopic
approach for liver resection are diminishing. Future studies
are necessary to delineate the persistent barriers for con-
tinued adaptation of the laparoscopic approach.
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OP-I.07 THE EFFECT OF ALCOHOL ON
SIRT1 EXPRESSION AND FUNCTION IN
ANIMAL AND HUMAN MODELS OF
HEPATOCELLULAR CARCINOMA
K. Thompson1, J. Humphries2, D. J. Niemeyer1,
D. A. Iannitti1, D. Sindram1 and I. McKillop1
1Carolinas Medical Center, HPB Surgery, Charlotte, NC;
2University Of North Carolina At Charlotte, Department Of
Biology, Charlotte, NC
Risk factors for HCC include chronic ethanol (EtOH) con-
sumption. Sirt1 is a deacetylase implicated in alcohol-
induced liver injury and overexpressed in HCC. The aims of
this study were to investigate Sirt1 expression in models of
EtOH feeding and HCC, and in human HCC cells with dif-
fering alcohol metabolizing profiles. Juvenile C57BL/6 and
B6C3 mice were injected with DEN and randomized to
receive water or 10%-EtOH for 8 Wks when 36 Wks old.
Livers were analyzed for HCC incidence, size and Sirt1
expression. In parallel, human HepG2 HCC cells or HepG2
cells transfected with ADH and CYP2E1 were treated with
alcohol (0–50 mM) and/or 10 μM CAY10591.B6C3 mice
exhibited significantly elevated Sirt-1 expression vs.
C57BL/6 mice and Sirt-1 expression was elevated in HCC
vs.non-tumor liver. However, EtOH-feeding did not further
alter Sirt1 expression in mice of either background despite
EtOH increasing size and incidence of HCC in B6C3 mice.
In vitro, VL-17a-cells exhibited significantly greater alcohol
metabolism vs.HepG2-cells and EtOH treatment signifi-
cantly decreased Sirt1 expression in VL-17a-cells, an effect
not observed in HepG2. EtOH-treatment stimulated VL-17a-
cell growth but not HepG2 cells and EtOH-dependent
changes in VL-17A-cell growth were abrogated by
CAY10591. Sirt1 expression correlates with HCC suscep-
tibility in different mouse strains, but not further affected by
alcohol. Conversely, Sirt1 expression and function is directly
influenced by alcohol metabolism in HCC cells. These dis-
crepancies in Sirt1 expression-function may reflect differ-
ences in enzyme expression vs. activity or changes in genes
that are targeted for deacetylation during tumor progression
in the setting of alcohol feeding-treatment.
OP-I.08 RISK FACTORS FOR REPEAT
CHEMOEMBOLIZATION FOR
HEPATOCELLULAR CARCINOMA
J. White, D. T. Redden, M. K. Bryant, D. P. Dorn,
S. Saddekni, A. K. Aal, S. H. Gray, D. E. Eckhoff and
D. A. DuBay
University of Alabama at Birmingham, Birmingham, AL
Background: Repeat chemoembolization (TACE) is a
common intervention performed for hepatocellular carci-
noma (HCC). The purpose of this study is to measure risk
factors associated with repeat TACE.
Methods: Between 2007 and 2012, patient and tumor vari-
ables were collected on 262 patients treated with a first TACE
procedure as an initial oncologic intervention for HCC at a
single University Hospital.
Results: Repeat TACE was performed in 66/262 (25%)
patients: 2 TACE in 53 and 3 TACE in 11 and 4 TACE in 2.
HCC necrosis, measured by mRECIST criteria after first
TACE, was lower in patients who subsequently received a
repeat TACE (p < 0.05). The following factors were predic-
tive of repeat TACE on univariate analysis: more than 1
tumor (p = 0.03), size (p = 0.01), total tumor diameter
(p = 0.001), and age (p = 0.008). On multivariable analysis,
only total tumor diameter (OR 2.76/cm, 95% CI 1.45–5.25,
p = 0.002) and increasing age (OR 1.04/year, 95% CI 1.00–
1.07, p = 0.03) were predictive of repeat TACE. Interestingly,
measures of liver function, TACE vehicle (lipiodol vs. drug
eluting beads), and TACE approach (selective vs. non-
selective) were not predictive of repeat TACE. After censor-
ing for liver transplantation, median survival was not
statistically different among patients that received repeat
TACE procedures (1 TACE 26.1 months vs. >1 TACE 21.1
months, p = 0.70). Liver Transplantation was less common in
patients with repeat TACE (7.5% vs. 20.6%, p = 0.01).
Conclusion: Receiving a repeat TACE procedure is associ-
ated increased HCC tumor burden and/or subtotal TACE-
induced HCC necrosis. Importantly, repeat TACE was not
associated with lower overall survival.
OP-I.09 STARTING A NEW
LAPAROSCOPIC LIVER SURGERY
PROGRAM: INITIAL EXPERIENCE AND
IMPROVED EFFICIENCY
S. Liang1 and S. Jayaraman1,2
1Division Of General Surgery, University Of Toronto,
Toronto, ON; 2HPB Service, St. Josephs Health Centre
Toronto, Toronto, ON
This study evaluates the safety and outcomes of introducing
a laparoscopic liver program to a hospital. This is a retro-
spective review of a prospectively acquired database of all
laparoscopic liver resections between August 2010 and July
2013 at St. Joseph’s Health Centre, Toronto. The primary
outcome was safety defined as mortality, major morbidity,
and negative margins. Secondary outcomes included other
perioperative outcomes. Non-parametric tests were used to
compare the first (Group A) and second (Group B)
18-months of the experience. There were 19 patients in
Group A, and 25 in Group B with 8 major resections in
Group A, and 5 in Group B. Group A had the only mortality
due to portal and hepatic vein thrombosis resulting in liver
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failure. There was no statistical difference between the
groups in major complications (10.6% vs. 16%, p = 1), or
length of stay (3 vs. 4 days, p = 0.59). In each group, there
was one case that required intra-operative margin revision.
One case in Group B had a positive parenchymal margin on
final pathology. There was a significant decrease in operative
time (210 vs. 164 min, p = 0.013) between the groups,
explained by improvement in the operative times of major
resections (296 vs. 193 min, p = 0.048). Furthermore, there
was a significant increase in procedures performed for malig-
nancy (34% vs 84%, p = 0.002). This study demonstrates that
laparoscopic liver resection can be safely introduced into a
hospital. The decrease in operative time despite increasingly
complex cases is likely a reflection of increased efficiency
with major resections.
OP-I.10 LAPAROSCOPIC CAUDATE
LIVER RESECTION
S. Lee, A. Hauch, E. Kane, E. Kandil and J. Buell
Tulane Transplant Institute, Tulane University School Of
Medicine, New Orleans, LA
Background: Laparoscopic caudate lobe resection is a fea-
sible, yet still infrequently performed procedure. As profi-
ciency and acceptance of laparoscopic techniques for
hepatectomy progress among liver surgeons, data is needed
to guide whether patients with anatomically challenging
locations can be better treated with a laparoscopic approach.
To date, perioperative outcomes following laparoscopic and
open approaches have not been compared.
Methods: Cohorts of 22 patients undergoing laparoscopic
and 20 patients undergoing open caudate resection were
matched based on preoperative criteria and compared.
Caudate resections with and without additional
segmentectomy were included. Outcomes included survival,
operating time, surgical margin, cancer recurrence, transfu-
sion requirements, ICU utilization, and length of stay.
Results: Open resection had a longer operating time (5 vs.
3 hrs, p = 0.004), increased blood loss (425 vs. 150 mL,
p = 0.008), and was more likely to require post-operative
critical care (60.0 vs. 13.6%, p = 0.002). Length of stay was
not significantly different between groups (7.0 vs. 5.5days,
p = 0.111). Morbidity was 13.6% in the laparoscopic group
compared to 40.0% in the open group (p = 0.052). R0
margins were achieved in 71.4% of laparoscopic versus
78.6% of open resections (p = 1.0). Rates of recurrence of all
cancers appeared to be higher in the laparoscopic group, but
this was not significantly different when compared to open
resection.
Conclusion: The laparoscopic approach is a viable option
for caudate lobe resection in select patients. Compared to an
open approach, laparoscopic resection may benefit patients
in terms of shorter operations, less operative blood loss,
decreased ICU utilization, and fewer post-operative
complications.
OP-I.11 LIVER RESECTION IN THE
ELDERLY FOR COLORECTAL LIVER
METASTASIS: OUTCOMES OF
OCTOGENARIANS
E. Simoneau, M. Shaheen, A. Salman, P. Chaudhury,
M. Kyres and P. Metrakos
Division Of Hepatopancreatobiliary Surgery, McGill
University Health Center, Montreal, QC
Introduction: Liver resections in elderly patients(>70 year
old) have previously been shown to be safe, tolerable and
with similar outcomes. However these reports made com-
parisons to young patients and a combination of different
diagnoses, which all have inherently different outcomes. The
aims of our study were to evaluate the perioperative course of
very elderly patients(over 80 years old) with colorectal liver
metastasis(CRCLM).
Methods: A retrospective study was conducted identifying
elderly patients undergoing liver resections for CRCLM
between 1996–2013. Baseline characteristics, complications
and perioperative mortality were obtained.
Results: 65 patients were included, 17 patients over 80
years old (80+) and 48 patients in a less elderly group (75–79
years-old). Resectability was 88.2% and 91.7% in the 80+
and 75–79 groups respectively.There was no difference in
baseline characteristics and types of procedure done (60.0%
vs 43.2% major resections in 80+ vs 75–79 groups respec-
tively, p = 0595). Post-operatively, the octogenarian group
had more intra-abdominal collections (20.0% vs 2.3%,
p = 0470) and length of stay was longer (13(7–17) days vs
9(6–11) days, p = 0.0456). Perioperative mortality was the
same, with 2 deaths in the 75–79 group compared to 1 death
in the 80+ group.
Conclusion: This is the largest series reported to date of
octogenarians with CRCLM undergoing liver resection. In
this patient population, liver resection may be performed
with similar perioperative mortality to a younger patient
cohort. There appears to be a greater risk of intra-abdominal
collection and longer length of stay in the octogenarian
group. Selected patients over 80 may benefit from resection
of CRCLM.
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OP-I.13 SURGERY AND STEREOTACTIC
BODY RADIOTHERAPY (SBRT): A
COMBINED APPROACH FOR LOCAL
CONTROL OF LIVER CANCER
N. L. Thai, K. Tom, A. Khan, P. Abrams, J. Oliva,
A. Kirichenko and M. Szramowski
Allegheny Health Network, Pittsburgh, PA
Combined surgery and radiation therapy can allow patients
with larger hepatic tumor burdens to receive aggressive local
therapy. Recent advances in SBRT have made radiation more
focused, allowing for precise eradication of liver tumors. At
our facility, the local control rate is 100% for tumors <=4 cm
at 2 years. We initiated a prospective study to evaluate the
combination of radiation and surgery in patients that other-
wise may not have qualified for aggressive local treatment.
The 26 patients had hepatic masses of varying origins. Eight
patients underwent surgical resection of some lesions and
SBRT to others based on inaccessibility of the tumors to just
one modality. Two patients received up-front radiation to
downsize the tumor prior to resection. Ten patients under-
went SBRT as a bridge to liver transplantation. Six patients
were originally outside of Milan criteria for transplant.
There have been no recurrences at SBRT sites or after trans-
plant at up to 41 months. Two resection patients have devel-
oped extra-hepatic metastases, and 5 have liver lesions at
new locations. One patient had 7 colorectal metastases
resected, followed by SBRT to an 8th lesion. He has no
known disease at 41 months. Ten patients received SBRT as
a bridge to transplant; 8 of these have been transplanted
without tumor recurrence at up to 35 months. Six patients
were successfully downsized to within Milan criteria using
radiation. This proof-of-concept study demonstrates that
radiation therapy can be used in conjunction with a surgical
approach to expand the indications for local control of liver
cancers.
OP-I.14 NOVEL EVALUATION FOR
HEPATIC FUNCTIONAL RESERVE
AFTER LIVER RESECTION IN
COMBINATION WITH 3D-CT AND
99MGSA SCINTIGRAPHY
M. TANIGUCHI1, A. Okizaki2, K. Watanabe1, K. Uchida1,
K. Imai1, N. Shuke2 and H. Furukawa1
1Division Of Gastroenterologic And General Surgery,
Asahikawa Medical University, Asahikawa, HOKKAIDO;
2Department Of Radiology, Asahikawa Medical University,
Asahikawa, HOKKAIDO
Background and Aim: It is important to develop accurate
diagnostic tools that can predict the risk of poor hepatic
functional reserve (PHFR) after liver resections. In this study,
the role of preoperative liver scintigraphy and CT volumetric
measurement of the liver in the preoperative risk assessment
for PHFR was evaluated.
Patients and method: Sixty-four patients who were sched-
uled for liver resection more than sectionectomy because of
liver tumors were enrolled in this study. Indocyanine green
clearance, technetium -99m -diethylenetriaminepentaacetic
acid-galactosyl human serum albumin scintigraphy (99mTc-
GSA), remnant liver volume calculated by CT were esti-
mated preoperatively. 99mTc-GSA, and conventional liver
function tests on 14 and 28 days after liver resection were
estimated postoperatively. The correlations between pre and
postoperative parameters were evaluated. Multivariate analy-
sis and receiver operating characteristics analysis was per-
formed to assess the risk of PHFR.
Result: Significant correlations were observed between
postoperative 99mTc-GSA studies and conventional liver func-
tion tests. Preoperative 99mTc-GSA clearance times remnant
liver volume (GSA × RLV) showed better correlation with
postoperative 99mTc-GSA studies and conventional liver func-
tion tests than preoperative 99mTc-GSA clearance alone, or
remnant liver volume. According to multivariate analysis,
GSA × RLV was the only significant independent predictor of
PHFR. No patients with GSA × RLV above 200 manifested
poor hepatic functional reserve. Using a GSA × RLV of 180,
it was possible to predict postoperative PHFR at a sensitivity
of 92%, specificity of 83%.
Conclusion: Preoperative measurement of 99mTc-GSA clear-
ance and the remnant liver volume on CT proved valuable in
assessing the risk of PHFR after liver resection.
OP-I.15 TUMOR SIZE INDEPENDENTLY
IMPACTS SURVIVAL IN PATIENTS
UNDERGOING SURGERY FOR
HEPATOCELLULAR CARCINOMA
O. C. Kutlu, M. Wachtel and S. Dissanaike
Texas Tech University Health Sciences Center, Lubbock,
TEXAS
Background: Recently the validity of tumor size as a pre-
dictor of survival has been questioned. Posited was the notion
that analysis of a large database might help assess this
question.
Methods: A SEER case listing session acquired patients
with hepatocellular carcinoma between 2004–6, with known
surgical, radiotherapy, and race status. All were M0 and N0
or NX at diagnosis. Variables and data stratifications are
provided below. Important proportional hazards assumption
violations were detected and 101 of the 4,863 (2.1%) patients
were lost to follow-up, binomial logit regression estimated
odds ratios (OR), with 1.25th and 98.75th percentiles of
10,000 bootstrap replicates being 97.5% confidence inter-
vals. Two multivariate regression analyses were performed,
one 2 y, one 4 y post diagnosis; null hypotheses were rejected
when P < 0.05/2 = 0.025.
Results: Recorded were 2,683 (55.2%) deaths at 2 y and
3,324 (68.4%) at 4 y. Compared with tumors 1–50 mm,
51–100 mm were associated with a worse outcome, as were
100+ mm. Compared with patients who underwent resection,
those who underwent local extirpation or did not undergo
surgery fared worse while those who underwent transplanta-
tion did better. Although 40–54 y and 55–69 y were not
shown to differ from 18–39 y patients, 70+y patients fared
worse. Asians/Native Americans/Pacific Islanders survived
more often than Whites. Gender or radiotherapy didn’t
increase odds of death. (Wald’s χ2 test, P > 0.025).
Conclusions: Tumor size proved an important predictor of
survival. Although 70+y patients had increased risks of
death, this was not shown to be the case for 40–54 y or
55–69 y patients.
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OP-I.16 BLOCKING CD47 PROMOTES
PHAGOCYTOSIS OF HUMAN
HEPATOCELLULAR CARCINOMA CELLS
Z. Xiao1, K. Ott1, Y. Lin1, C. Chen1, L. Lin1, G. Upadhya1,
P. Manning3, W. Frazier 2, T. Mohanakumar 1 and
W. Chapman1
1Department Of Surgery,Washington University School Of
Medicine, Saint Louis, MISSOURI; 2Department Of
Biochemistry & Molecular Biophysics ,Washington
University School Of Medicine, Saint Louis, MISSOURI;
3Vasculox, Inc. St Louis, Saint Louis, MISSOURI
CD47 allows cancer cells to evade immunologic surveillance
via a ‘don’t eat me’ signal. No data exists supporting the role
of CD47 in hepatocellular carcinoma (HCC). We aimed to
determine CD47 expression in HCC and to evaluate the
ability of blocking monoclonal antibody in promoting
phagocytosis in vitro.
Methods: We determined the CD47 expression in HCC
samples and normal livers by immunohistochemistry, and in
human hepatocytes and HepG2 cells by flow-cytometry. Tox-
icity of CD47mAb to HepG2 cells was determined by MTT.
To assess phagocytosis, macrophages from NOD/SCID/r
mice were co-cultured with HepG2 cells under three condi-
tions: IgG control, non-blocking mAb 2D3,and blocking
CD47mAb400. A phagocytic index was calculated by count-
ing cells under confocal microscopy.
Results: Immunofluorescence staining revealed that CD47
expression is higher in HCC (9/10) than in normal liver (0/6)
(p < 0.001). Immunofluorescence intensities of HCC, adja-
cent tissues and normal liver were 88.8 ± 2.50, 23.9 ± 1.45
and 18.0 ± 0.50 respectively. CD47 expression was
upregulated in HepG2 but absent in human hepatocytes
(p < 0.001). HepG2 cells incubated overnight with CD47
mAb did not demonstrate any cell death. Phagocytosis of
HCC cells was significantly increased by the blocking
CD47mAb400 compared to control groups (both p < 0.001).
The phagocytic index of the anti-CD47mAb400, IgG and 2D3
were 71.1 ± 1.08, 11.5 ± 0.36 and 9.6 ± 0.61 respectively.
Conclusions: CD47 is more highly expressed in HCC and
on HepG2 cells than in normal tissue or hepatocytes.CD47
blockade increased macrophage phagocytosis of HCC cells
suggesting a role for CD47 blockade in managing HCC.
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OP-I.18 TACHOSIL VERSUS SURGICEL
ORIGINAL FOR THE SECONDARY
TREATMENT OF LOCAL BLEEDING IN
ADULT PATIENTS UNDERGOING
HEPATIC RESECTION
Y. Genyk1, T. Kato2, J. J. Pomposelli3, K. W. Lophaven4
and W. C. Chapman5
1University Of Southern California, Los Angeles, CA;
2Columbia University Medical Center, New York, NY;
3Lahey Clinic Medical Center, Burlington, MA; 4Takeda
Development Centre Europe, Langebjerg 1, ROSKILDE;
5Washington University In St Louis, St. Louis, MO
Background: TachoSil® is an absorbable fibrin sealant col-
lagen patch that is currently licensed in the US as an adjunct
to hemostasis in cardiovascular surgery. This randomized,
prospective, multicenter study compared the efficacy and
safety of TachoSil® versus Surgicel® Original as standard
adjunctive treatment for hemostasis in patients undergoing
open or laparoscopic hepatic resection.
Methods: A total of 224 hepatic resection patients with
minor to moderate bleeding from the resection area after
primary control of arterial bleeding or major venous hemor-
rhage were randomized to treatment with TachoSil®
(n = 114) or Surgicel® Original (n = 110). Primary outcome
was the proportion of patients with intraoperative hemostasis
at target bleeding site within 3 minutes of application of
randomized treatment.
Results: Hemostasis within 3 minutes was achieved by 92
(80.7%) patients in the TachoSil® group and 55 (50.0%) in
the Surgicel® Original group (OR 4.87; 95% CI: 2.55, 9.29;
P < 0.001). The proportion of patients with hemostasis at 5
minutes was also significantly higher in the TachoSil® group
than the Surgicel® Original group (94.7 % vs 76.4%,
P < 0.001), while the time to hemostasis was significantly
shorter (P < 0.001). Most adverse events (AEs) were mild in
severity and considered to be unrelated to trial treatment. AEs
considered to be treatment-related were reported for 5
patients in the TachoSil® group and 4 patients in the
Surgicel® Original group.
Conclusions: TachoSil® was superior to Surgicel® Origi-
nal for achieving hemostasis in adult patients undergoing
hepatic resection. TachoSil® was well tolerated, with no
evidence of increased frequency of AEs compared with
Surgicel® Original.
OP-I.19 HEPATIC STELLATE
CELL-DERIVED TENASCIN-C IS
ASSOCIATED WITH OBESITY-INDUCED
HEPATOCELLULAR CARCINOMA
T. Li, J. H. Benbow, T. L. Walling, A. C. Smith,
I. H. McKillop, D. Sindram, K. J. Thompson and
L. W. Schrum
Carolinas Medical Center, Charlotte, NC
Obesity is an independent risk factor for developing hepato-
cellular carcinoma (HCC), and nonalcoholic fatty liver
disease (NAFLD) is a consequence of obesity. Hepatic stel-
late cell (HSC) activation is essential for the development of
NAFLD-induced fibrosis/cirrhosis and HCC. Activated
HSCs secrete tenascin-C (TnC), an extracellular matrix gly-
coprotein, which can be modulated by Rev-erbα, a nuclear
repressor that plays a key role in HSC activation and the
fibrogenic response. The aim of this study was to determine
if increased secretion of TnC from activated HSCs is associ-
ated with obesity-induced HCC.
Methods: Primary rat HSCs and hepatocytes were isolated
from male Sprague-Dawley rats. TnC secretion, detected by
immunoblots, was assessed in activated HSCs with or
without Rev-erb agonists (10 μM). Hepatocytes were treated
with TnC (50 nM) and/or LPS (1 μg/ml) and inflammatory
gene expression was measured by RealTime PCR. Tissue
from mice fed a high fat diet (HFD) or control diet (CD) +/−
diethylnitrosamine (DEN, liver tumor promoter) was
assessed for inflammatory gene expression and HSC
activation.
Results: TnC secretion increased during HSC activation
which was blocked by Rev-erb agonists. TnC synergized
with LPS to increase inflammatory gene expression (IL-6,
IL-8, TNFα) in hepatocytes. Similar results were observed in
livers of HFD compared to CD. Increased TnC expression
was associated with activated HSCs in HFD + DEN animals
compared to CD + DEN.
Conclusion: HSC-derived TnC may be a key regulator of
obesity-induced HCC and suggests TnC and upstream regu-
lator Rev-erb as potential therapeutic targets.
OP-I.20 PREOPERATIVE ASSESSMENT
OF REMNANT LIVER FUNCTION
FOLLOWING HEPATECTOMY BY
HEPATOBILIARY SCINTIGRAPHY AND
INDOCIANINE GREEN CLEARANCE
K. Okada, H. Kinoshita, Y. Sakamoto, S. Yao,
T. Yamamoto, K. Inoguchi, R. Hosotani and S. Kaihara
Kobe City Medical Center General Hospital, Kobe,
HYOGO
Introduction: It is extremely important to assess the limit of
hepatectomy before operation to prevent fatal postoperative
liver failure. In our department, we determine the resection
area of hepatectomy using 99mTc-GSA with single-photon
emission computed tomography (GSA-SPECT) and
indocianine green clearance (KICG) to estimate postopera-
tive hepatic function. We report the efficiency of our assess-
ment methods.
Method: Using simulated surgery on fusion images of
SPECT and CT, we calculate residual ratio of the functional
volume after hepatectomy (RFV). We multiply the value of
K-ICG by the RFV and calculate the predicted K-ICG of
remnant liver (Rem-KICG). We define it operable when
Rem-KICG is over 0.05. In our hospital between January
2006 and November 2012, there are 43 cases which satisfy
that conditions. The relationships between Rem-K-ICG and
postoperative hepatic function parameters are analyzed. We
use Speaman’s rank correlation coefficient to analyze
correlations.
Result: In analysis of the 43 cases, there are significant
relationships between Rem-KICG and postoperative peak
serum total bilirubin (T-Bil), peak prothrombine time(PT-
INR) (T-Bil ρ = −0.3567 p = 0.0189, PT-INR ρ = −0.4260
p = 0.0044). There are only 3 cases have failed in Grade B
post hepatectomy liver failure (PHLF in ISGLS criteria). The
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3 cases have refractory ascites, however, they don’t fail in
critical liver failure. Duration of hospital stays is 6–72 days
(median 12days).
Conclusion: Using Rem-KICG, probably we can assess
postoperative hepatic function. We conducted hepatectomy
safely by using the operable criteria(Rem-KICG > 0.05). The
criteria may be useful to indicate the acceptable limit of
hepatectomy before operation.
OP-I.21 CHARACTERIZATION OF
PANCREATICO-ENTERIC
ANASTOMOTIC HEALING IN A
PORCINE SURVIVAL MODEL
Y. S. Khajanchee1, W. Johnston1, C. B. Bifulco2,
M. A. Cassera1, C. W. Hammill1 and P. D. Hansen1
1Providence Portland Cancer Center, Hepatobiliary And
Pancreatic Surgery Program, Portland, OREGON;
2Providence Portland Cancer Center, Department Of
Pathology, Portland, OREGON
Objective: Leakage from the pancreatico-enteric anastomo-
sis after pancreatico-duodenectomy is the single most impor-
tant cause of postoperative morbidity and mortality.
Histological studies of ileal and colonic anastomoses have
provided valuable insights regarding causes of anastomotic
failure. However, this crucial information is lacking for
pancreatico-enteric anastomoses. The aim of the current
study is to characterize the histology, assess collagen
deposition and bursting strength of pancreatico-enteric anas-
tomoses in a porcine survival model during the early post-
operative period when dehiscence is most likely to occur.
Methods: Under general-anesthesia, pancreatico-
duodenectomy was performed followed by two layered end-
to-side pancreatico-enteral anastomosis. Animals were
survived for five-days. Drain amylase was measured on post-
operative day (POD) 3 and 5. Animals were euthanized on
POD-5 and the pancreatico-enteral anastomosis specimen
was resected en-block. Bursting pressure testing was per-
formed using Gastrograffin solution under direct fluoro-
scopic guidance. Histological sections of the anastomoses
were prepared with trichrome staining and were examined
under high power light microscopy.
Results: Postoperative drain amylase were 10 times greater
than serum amylase levels in both animals indicating clinical
fistula. However, on bursting pressure testing, no leakage of
contrast was noted at pressures >300 mmHg. Gross exami-
nation and microscopic examination of the anastomotic site
revealed excellent healing with significantly higher quan-
tities of collagen deposition at the pancreatico-enteral
anastomotic site as compared to entero-enteral anastomosis.
Conclusion: Our initial results indicate that healing of
pancreatico-enteral anastomosis is much better than entero-
enteral anastomosis during the early post-operative period.
High drain amylase level does not necessarily indicate a
pancreatic fistula.
OP-I.22 PREOPERATIVE
NEUTROPHIL-TO-LYMPHOCYTE RATIO
(NLR) AND SERUM CA19-9 AS
SIGNIFICANT PREDICTORS FOR
PANCREATIC HEAD CANCER
T. Asaoka, A. Miyamoto, K. Yamamoto, N. Haraguchi,
M. Miyake, K. Nishikawa, M. Hirao, M. Ikeda,
M. Sekimoto and S. Nakamori
Department Of Surgery, Osaka National Hospital, Osaka,
OSAKA
Background: Recently, several preoperative proinflamma-
tory markers and nutritional factors such as neutrophil-to-
lymphocyte ratio (NLR) and prognostic nutrition index (PNI)
have been reported as significant predictor for poor prognosis
of various malignant tumors. In this study, we evaluated the
prognostic values of these preoperative parameters in
patients with resectable pancreatic head cancer.
Methods: We retrospectively reviewed consecutive patients
who underwent pancreatoduodenectomy for pancreatic head
cancer between 2007 and 2012. A total of 46 patients were
enrolled in this analysis. Preoperative parameters such as
CRP, CA19-9, NLR and PNI at the time of presentation were
recorded as well as overall survival.
Results: In multivariable analysis preoperative high NLR
(>2.7) and high CA19-9 (>232) were independent prognostic
factors for poor survival (P value: 0.03 and 0.025 respec-
tively). Kaplan-Meier survival analysis demonstrated the
overall 2-year survival rate in patients with high NLR or high
CA19-9 were 37.5% compared with 89.9% in patients with
low NLR and low CA19-9.
Conclusion: Preoperative NLR and serum CA19-9 offer
significant prognostic information associated with overall
survival following pancreatoduodenectomy in the patients
with pancreatic head cancer.
28 Abstracts
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 1), 1–99
OP-I.24 USE OF GLAND AND TUMOR
CHARACTERISTICS AND
PREOPERATIVE CT SCANS TO PREDICT
PANCREATIC FISTULA AFTER DISTAL
PANCREATECTOMY
C. Johnston1, L. Harmon2, L. Haykin1, J. Shen1, H. Hahn2,
D. Coy2, M. Lasarev3, C. Mathews1, M. Cassera1,
M. Brown1, R. Wolf1, P. Hansen1, C. Hammill1, A. Alseidi2
and P. Newell1
1Providence Portland Cancer Center, Portland, OR;
2Virginia Mason Medical Center, Seattle, WA; 3Oregon
Health And Science University, Portland, OR
Background: Postoperative pancreatic fistula (POPF)
remains the dominant cause of morbidity following distal
pancreatectomy. Preoperative risk stratification of patients
undergoing distal pancreatectomy would be useful for treat-
ment algorithms and clinical trials.
Methods: Risk factors for POPF in 199 consecutive patients
undergoing distal pancreatectomy at two major institutions
were recorded retrospectively. Gland density was measured
on noncontrast CT scans (n = 101), and histological scoring
of fat infiltration and fibrosis was performed by a pathologist
based on H&E staining (n = 120). Recursive partitioning was
used to construct a decision tree to predict POPF based on
eleven variables.
Results: 42 patients (21%) developed a clinically significant
POPF (ISGPF Grade B or C) within 90 days. Univariate
analysis of age, operative approach, method of gland
transection, splenectomy, staple line reinforcement, and
pathologic diagnosis in 199 patients showed none were pre-
dictive of POPF. Fat infiltration was significantly associated
with gland density (p = .0013), but density did not predict
POPF (p = 0.5). ROC curve analysis did not identify values
for gland thickness at the margin that predicted POPF (area
under curve = 0.635). Recursive partitioning resulted in a
decision tree that predicted POPF in this cohort with a
misclassification rate of <15% using gland fibrosis (histol-
ogy), density (HU), margin thickness (cm), and pathologic
diagnosis.
Discussion: This multicenter study shows that no single
perioperative factor reliably predicts POPF after distal pan-
createctomy. However, a novel decision tree was constructed
using recursive partitioning that predicts POPF with >85%
accuracy. Further work is required to validate the applicabil-
ity of this model to clinical practice.
OP-I.25 HIGHER LYMPH NODE RATIO
PREDICTS EARLY RECURRENCE AFTER
CURATIVE RESECTION FOR
PANCREATIC ADENOCARCINOMA
E. W. Gilbert, N. W. Bronson, T. Kaur, K. Billingsley and
B. C. Sheppard
Oregon Health & Science University, Portland, OR
Introduction: The majority of patients who undergo resec-
tion for pancreatic adenocarcinoma (PDAC) are diagnosed
with recurrence. In this study we aim to characterize the
pattern of recurrence and the predictors of early recurrence
following curative resection.
Methods: Patients with PDAC surgically resected between
1996 and 2010 were retrospectively reviewed and categorized
into early (<12 months) or late (>/=12 months) recurrence. Mul-
tivariate Cox proportional hazard models were used to estimate
the effects of variables on pattern of recurrence. Survival esti-
mates were calculated using Kaplan Meier analysis.
Results: From 1996–2010, 256 patients underwent PDAC
resection at a single-center. Overall median survival was 17
months (95% CI = 15–22) and disease free survival was 15
months (95% CI = 13–21). Recurrence was documented in
107 patients at a median of 315 days (IQR = 154–471).
Thirty-two (30%) recurred regionally, 69 (64%) had distant
metastasis and 6 (6%) had both. In multivariate analysis, R1
resection, lymph node positivity and a higher lymph node
ratio carried an increased risk of recurrence (p < 0.05 for all).
Patients with early (64, 60%) compared to late recurrence (43,
40%) were significantly more likely to have a distant recur-
rence (72% vs. 53%, p = 0.037), a trend toward lymph node
positivity (70% vs. 53%, p = 0.076) and to have a higher
median lymph node ratio (0.167 vs. 0.050, p = 0.04; Table 1).
Conclusion: A higher ratio of positive over total number of
lymph nodes predicts early recurrence following surgical resec-
tion for pancreatic adenocarcinoma. Patients who recur early are
more likely to be diagnosed with a distant metastasis.
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OP-I.26 SINGLE-INSTITUTION
EXPERIENCE WITH RESECTION OF
SIDE-BRANCH IPMN: A REVIEW OF
PRE-OPERATIVE CHARACTERISTICS
AND FINAL PATHOLOGIC DIAGNOSIS
J. D. Dortch, J. A. Stauffer and H. J. Asbun
Mayo Clinic-Florida , Jacksonville, FL
Background: Given the malignant potential of main duct
IPMN (M-IPMN) surgical resection is generally indicated.
With regard to side branch IPMN (SB-IPMN), resection
versus observation is a topic of debate. We present a single
institution experience with surgical resection of SB-IPMN.
Methods: A retrospective review of all patients undergoing
resection for IPMN from 2002–2013 was performed. Our
specific focus was on isolated SB-IPMN with non-malignant
FNA cytology. Preoperative clinical characteristics and diag-
nostic selection criteria were reviewed to determine associa-
tion with pathologic diagnosis and clinical outcomes.
Results: A total of 147 patients undergoing resection for
IPMN were identified. Of these, 80 patients (54%) had a
component of M-IPMN or invasive disease on FNA, leaving
67 (46%) patients with SB-IPMN and non-malignant cytol-
ogy. The results of the latter group are summarized in the table.
Ductal adenocarcinoma within SB-IPMN was found in 9
patients (13%). The mean diameter (cm) of benign SB-IPMN
was 2.0 (Range: 0.3–5.7) (SD ± 1.1) vs. that of malignant
SB-IPMN which was 3.1 (Range: 1.5–6.0) (SD ± 1.3) (p =
0.014). Of the 9 patients found to have malignant SB-IPMN,
symptoms, mural nodules, and septations were found in 6
(67%), 2 (22%), and 5(56%), respectively. Tumor staging was
as follows: IA(2) IB (2) 2A(4) 2B (1). 1/9 (11%) patients with
malignant SB-IPMN died during the study period.
Conclusion: With proper selection criteria, SB-IPMN is
associated with a low rate of invasive pancreatic ductal
adenocarcinoma at the time of resection. Nevertheless, given
the demonstrated incidence of malignancy, appropriate
operative candidates should undergo resection.
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OP-I.27 PANCREATIC CANCER
METASTATIC TO A LIMITED NUMBER
OF LYMPH NODES DOES NOT
ADVERSELY AFFECT OUTCOME
M. Kukar, S. W. Badwin, K. Attwood, N. Wilkinson,
S. N. Hochwald and B. Kuvshinoff II
Roswell Park Cancer Institute, Buffalo, NY
Metastatic nodal disease in pancreatic cancer is generally
associated with poor prognosis; however the current AJCC
staging does not take into account the number of positive
lymph nodes or their ratio. This study aims to relate the
extent of metastatic lymph node involvement with survival
in pancreatic cancer. A prospective database identified
patients undergoing resection for pancreatic adenocarci-
noma from 1999–2009. Patient characteristics were com-
pared using Wilcoxon or Kruskal Wallis test for continuous
variables, while categorical variables were compared using
Fisher’s exact or chi-square test. The survival outcomes
were summarized using Kaplan-Meier methods. Patients
(N = 165) were divided into 3 groups based on the number
of positive lymph nodes {0 (Group A), 1–2 (Group B), >3
(Group C)}. Group A (n = 55) and B (n = 55) were similar,
however patients in Group C (n = 55) were more likely to
have a higher T stage, be poorly differentiated, have
lymphovascular invasion, higher mean intraoperative blood
loss, have positive margins, in the uncinate process, and
more likely to have a Whipple. Median overall survival for
patients in each group was 25.5 months (A), 21 months (B)
and 12.3 months (C) (p < 0.001, Figure 1a), however no
difference was noted for survival between A and B
(p = 0.86). The ratio of involved lymph nodes less than 0.2
was also predictive of improved survival (p < 0.001, Figure
1b). Resected pancreatic cancer patients with 1–2 positive
lymph nodes or less than 20% involvement have a similar
prognosis to patients without nodal disease. Accurate
staging should consider stratification of the extent of nodal
involvement.
OP-I.28 VARIATIONS IN MEDICAL
ONCOLOGY UTILIZATION PRACTICES
BY PANCREATIC CANCER PATIENTS IN
A SINGLE PAYER HEALTH CARE
SYSTEM
S. Hurton1,2, G. Porter1,2, M. Walsh1 and M. Molinari1,2
1Department Of Surgery, Dalhousie University, Halifax,
NS; 2Department Of Community Health & Epidemiology,
Dalhousie University, Halifax, NS; 3Cancer Outcomes
Research Program, Cancer Care Nova Scotia, Halifax, NS
Population-based studies in the USA have shown that pan-
creatic cancer (PC) has the lowest rates of cancer-directed
therapy among solid organ malignancies. Socio-economic
factors, referral patterns and unequal access to health-care
might be responsible. Few studies examine PC patients living
in regions where health care is uniformly available. Main aim
of this study was to assess PC-directed therapy in a cohort of
patients diagnosed with PC in Nova Scotia (Canada). A
cohort of 1129 patients with PC was identified using the
Provincial Cancer Registry over a 10-year period (2001–
2010). Demographic, clinical and socio-economic data were
extracted through the linkage of multiple administrative data-
bases. Predictors of medical oncology health-care utilization
in PC patients were explored by multivariate analyses. Cura-
tive resection was performed in 163 patients (14.4%) and
palliation in 996 (85.6%). Of all resected patients, 45% were
referred to medical oncology for adjuvant therapy and 34.4%
of patients had a visit within 10 weeks. Among unresected
patients, 31% were referred for palliative chemotherapy.
There was greater attrition between referral to medical oncol-
ogy and a visit to medical oncology in resected patients vs.
unresected patients (14.1% vs. 4.6%). When adjusted for
socioeconomic status, distance from medical center and
rurality, only advanced age (P = 0.0092) and presence of
comorbidities (P = 0.0029) were significant predictors for
failure of PC-directed therapy (Table 1). The majority of
patients with PC did not receive cancer directed therapy.
Socioeconomic characteristics and distance to medical
centers did not have a significant effect in utilization of
adjuvant or palliative oncological treatments.
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OP-I.29 LONG TERM OUTCOMES FAVOR
PYLORUS PRESERVING
PANCREATICODUODENECTOMY OVER
DUODENUM PRESERVING PANCREATIC
HEAD RESECTION FOR CHRONIC
PANCREATITIS: A META-ANALYSIS AND
SYSTEMATIC REVIEW
P. B. Sukharamwala1, S. B. Ross1, S. Parikh1, C. E. Ryan1,
T. W. Wood1 and A. S. Rosemurgy1
1Florida Hospital Tampa, Tampa, FL; 2American
University Of Antigua, New York, NY
Introduction: Many consider the pancreatic head the
epicenter of chronic pancreatitis. Pylorus preserving
pancreaticoduodenectomy (PPPD) and duodenum preserv-
ing pancreatic resection (DPPHR) aimed at resecting pancre-
atic head are important treatment options. The aim of this
Meta analysis is to compare the long term outcomes of PPPD
versus DPHR in patients with chronic pancreatitis.
Methods: A systematic literature search was conducted
using Embase, MEDLINE, Cochrane and PubMed databases
on all studies published between January 1991 and January
2013 reporting intermediate and long term outcomes after
PPPD and DPHR for chronic pancreatitis. Outcomes of
interest were complete pain relief, quality of life, profes-
sional rehabilitation, exocrine insufficiency and endocrine
insufficiency.
Results: Eleven studies (seven RCT) were included com-
prising 692 patients. There was no significant difference in
complete pain relief between PPPD and DPPHR (odds ratio
(OR) 95% CI 0.82 [0.52, 1.30]; P = 0.43). However quality
of life (WMD 95% CI -12.25 [-15.20, -9.30] ; P < 0.00001)
and professional rehabilitation (OR 95% CI, 0.47 [0.28,
0.79]; P = 0.004) were significantly better for patients under-
going DPPHR compared to PPPD. This can be, in part,
attributed to significantly reduced exocrine insufficiency (OR
95% CI, 2.25 [1.43, 3.55]; P = 0.004) and endocrine insuffi-
ciency (OR 95% CI, 1.74 [1.10, 2.77]; P = 0.02) in patient
who underwent DPPHR.
Conclusions: There is no significant difference in postop-
erative pain relief in patients undergoing PPPD versus
DPPHR. Improved long term outcomes including quality of
life, professional rehabilitation and preservation of exocrine
and endocrine function, make DPPHR procedure more
attractive than PPPD for patients with chronic pancreatitis.
32 Abstracts
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 1), 1–99
OP-I.30 NEOADJUVANT
CHEMORADIATION DECREASES
LYMPH NODE RATIO IN BORDERLINE
RESECTABLE PANCREATIC DUCTAL
ADENOCARCINOMA
J. S. Peng, N. Ali, G. Falk, D. Joyce, C. O’Rourke,
J. McMichael, J. Wey, S. Chalikonda, K. M. El-Hayek and
R. M. Walsh
Cleveland Clinic Foundation, Cleveland, OH
Background: In patients undergoing pancreaticoduodenec-
tomy (PD) for pancreatic ductal adenocarcinoma (PDAC),
lymph node metastasis and higher lymph node ratio
adversely affect prognosis. This study aims to examine the
impact of neoadjuvant therapy on lymph node and margin
status in borderline resectable PDAC.
Methods: A neoadjuvant protocol was established at our
tertiary care institution in 2012 for all patients with border-
line resectable PDAC. These patients underwent diagnostic
laparoscopy and eligible patients received neoadjuvant
chemoradiation with a gemcitabine or 5-fluorouracil based
protocol. Patients were subsequently re-staged and those
without progression of disease underwent curative resection.
Fourteen patients who underwent PD after neoadjuvant
chemoradiation were compared to a control group of 28
patients who underwent PD without neoadjuvant therapy,
matched for age, sex, and tumor size. Baseline demographic,
operative and histopathologic characteristics were analyzed.
Results: The neoadjuvant and control groups were compa-
rable with respect to the number of lymph nodes harvested
(17.3 vs 15.5, p = 0.45), operative time (509 vs 440 minutes,
p = 0.11), blood loss (664 vs 476 mLs, p = 0.13), and post-
operative length of stay (11.6 vs 10.9 days, p = 0.76). In the
neoadjuvant group, there were more R0 resections (86 vs
61%; P = 0.043), more N0 stage (71 vs 21%; P = 0.002), and
a lower lymph node ratio (mean 0.045 vs 0.19; P = 0.03).
Conclusion: This single institution study demonstrates that
neoadjuvant chemoradiation in borderline resectable PDAC
shows favorable histopathologic outcomes, including
increased R0 resection, N0 stage, and lower lymph node
ratio. These results suggest a more favorable long-term prog-
nosis with neoadjuvant therapy.
OP-I.31 DELAYED GASTRIC
EMPTYING FOLLOWING
PANCREATICODUODENECTOMY:
INCIDENCE, RISK FACTORS, AND
HEALTHCARE UTILIZATION
S. Mohammed1,2, G. Van Buren1,2, A. McElhany1,2,
M. Issazadeh1,2, E. J. Silberfein1, D. A. Anaya1,
S. E. Hodges1,2 and W. E. Fisher1,2
1Baylor College Of Medicine, Houston, TX; 2Elkins
Pancreas Center, Houston, TX
Background: Delayed gastric emptying (DGE) is a frequent
complication following pancreaticoduodenectomy (PD).
Further examination of DGE and understanding its implica-
tions on healthcare utilization is important. This study char-
acterizes incidence and risk factors for DGE following PD
and examines healthcare utilization.
Methods: A prospectively-maintained database was retro-
spectively reviewed. DGE was classified using the Interna-
tional Study Group of Pancreatic Surgery consensus
definition. Subjects who developed DGE and those who did
not were analyzed using univariate and multivariate models.
Results: 276 patients underwent PD (>80% pylorus-
preserving with antecolic reconstruction and no enteric
feeding tubes). DGE developed in 49 patients (17.8%); 9.1%
grade A, 5.1% grade B, and 3.6% grade C. Demographic,
clinical, and operative variables were similar between
patients with DGE and those without. DGE patients were
more likely to experience multiple complications (32.6% vs
4.4% with ≥3 complications, p < 0.001), including pancre-
atic fistula (PF) (42.9% vs 18.9%, p = 0.001) and intra-
abdominal abscess (IAA) (16.3% vs 4.0%, p = 0.012). Only
9 (18.4%) patients experienced isolated DGE. Patients with
DGE had a longer hospital stay (median 12 vs 7 days,
p < 0.001) and were more likely to be discharged to transi-
tional care facilities (24.5% vs 6.6%, p < 0.001). On multi-
variate analysis, presence of pancreatic fistula (OR 5.02,
p < 0.001) was a significant predictor for DGE development.
Conclusion: Although DGE occurs in <20% of PD patients,
it is associated with significant increase in healthcare utiliza-
tion postoperatively. Patients with PF are at highest risk for
developing DGE and should be the target of future interven-
tions to improve management of DGE.
OP-I.32 PORTAL VEIN RESECTION IS
ASSOCIATED WITH IMPROVED
SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC CANCER
P. B. Sukharamwala, K. D. Patel, R. L. Klein, T. W. Wood,
A. F. Teta and A. S. Rosemurgy
Florida Hospital Tampa, Tampa, FL
Introduction: Pancreatic cancer with close proximity to the
portal or superior mesenteric veins is no longer considered
a contraindication to pancreaticoduodenectomy. With
improvements in staging, perioperative care, and surgical
experience, portal vein resection is undertaken more fre-
quently. This study was undertaken to compare long-term
survival after pancreaticoduodenectomy with or without
portal vein-superior mesentric vein resection.
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Methods: An Embase, MEDLINE, Cochrane, and PubMed
search was undertaken to identify published studies that
report long-term outcomes after portal vein-superior
mesenteric vein resection during pancreaticoduodenectomy
for pancreatic carcinoma from 1997 through 2013. Survival
rates between patients with portal vein resection and patients
without portal vein resection were compared. Data were
analyzed using hazard ratios and standard error. The hazard
ratios for all trials were pooled using an inverse variance
method.
Results: 21 studies compared survival with versus without
portal vein-superior mesenteric vein resection during
pancreaticoduodenectomy for pancreatic carcinoma. Patients
who underwent pancreaticoduodenectomy with portal vein
resection had better survival compared to patients who
underwent pancreaticoduodenectomy without portal vein
resection (hazard ratio (OR) 95% CI 0.89 [0.80, 0.98],
p = 0.02).
Conclusion: Long-term survival after pancreaticoduo-
denectomy with portal vein-superior mesenteric vein resec-
tion can be achieved. Given the improved survival rates
associated with pancreaticoduodenectomy and portal vein-
superior mesenteric vein resection, aggressive surgical resec-
tion and reconstruction should be undertaken for suspected
portal vein-superior mesenteric vein invasion during
pancreaticoduodenectomy for pancreatic carcinoma.
OP-I.34 ROLE OF SURGICAL
PALLIATION IN PATIENTS WITH
PANCREATIC DUCTAL
ADENOCARCINOMA (PDAC)
A. Abbasi1, R. Lo1, A. J. Moser1, J. F. Tseng1,
C. M. Vollmer2, M. P. Callery1 and T. S. Kent1
1Beth Israel Deaconess Medical Center Department Of
Surgery, Boston, MA; 2University Of Pennsylvania
Department Of Surgery, Philadelphia, PA
Introduction: With widespread availability of endoscopic
palliation for unresectable PDAC, fewer patients undergo
surgical palliation (SP). Contemporary data on this sub-
group of patients are limited. This study investigated out-
comes for surgically palliated patients, with a goal of
determining its role amongst palliative options for these
patients.
Methods: Retrospective chart review was conducted in a
high-volume pancreatic surgery institution. Patients included
those with PDAC (2003–11) who underwent diagnostic or
palliative operations only.
Results: Of 193 patients, 70 underwent diagnostic pro-
cedures only, mainly staging laparoscopy. 123 (64%) patients
underwent SP, most often (N = 96, 78%) when initial intent
was curative resection. Of these, 75 (78%) patients had
locally advanced disease at operation, and 21 (22%) had
metastasis. 27 (of 123) patients underwent SP because endo-
scopic palliation was not possible, and/or for tissue diagno-
sis. The majority of SP patients underwent biliary and/or
gastric bypass (N = 93, 75%). SP and diagnostic-only
patients were equally likely to start chemotherapy (84v81%,
p = 0.71), but time to initiation was longer (median 44v31d,
p = 0.013). Complications occurred (Table 1) but most were
minor (Clavien-Dindo 1–2, 78%). 30 d readmission rate was
11.3% (14 patients). Median survival was slightly longer for
SP patients, but was not statistically significant (11.2vs9.5 m,
p = 0.239).
Conclusion: Most complications following SP tended to
be minor, although major morbidity/mortality did occur.
Overall, SP patients were equally likely to enter palliative
chemo/radiotherapy and survival was slightly, but not signifi-
cantly, longer. Further study is warranted of the durability of
SP, particularly bypass, in the context of contemporary
ERCP capabilities, chemotherapy regimens, and survival.
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OP-I.35 PROPHYLACTIC
ANTICOAGULATION FOR SUPERIOR
MESENTERIC VEIN (SMV) OR PORTAL
VEIN (PV) NARROWING/OCCLUSION IN
BORDERLINE RESECTABLE (BLR)
PANCREATIC ADENOCARCINOMA (PC)
PATIENTS
A. N. Krepline, K. Duelge, B. George, P. Ritch,
B. A. Erickson, A. Mahmoud, E. J. Quebbeman,
K. K. Turaga, F. M. Johnston, T. C. Gamblin,
K. K. Christians, D. B. Evans and S. Tsai
Medical College Of Wisconsin, Milwaukee, WI
Background: BLR PC patients (pts) with significant
SMV/PV narrowing are at risk for developing mesenteric
venous thrombosis (MVT) which may prevent eventual pan-
createctomy. Prophylactic anticoagulation in this population
has unknown benefit.
Methods: From 2007–2013, BLR PC pts receiving
neoadjuvant therapy were classified by >50% narrowing of
the SMV/PV, SMA abutment, marginal performance status,
Ca19–9 >2000 U/mL, or having lesions indeterminate for
metastases. Anticoagulation status, radiographic measure-
ment of venous diameter, and clinicopathologic data were
abstracted.
Results: Eighty-four BLR PC pts were identified; 42 (50%)
had SMV/PV narrowing, 8 (10%) had short segment venous
occlusion, 24 (28%) had SMA abutment alone, and 10 (12%)
were BLR by other criteria. Of the 42 pts with SMV/PV
narrowing, the mean vessel diameter was 5.6 mm (standard
deviation 2.7 mm). Of the 50 pts with either SMV/PV nar-
rowing (42) or occlusion (8), 35 (70%) received either
prophylactic or therapeutic anticoagulation during their
neoadjuvant treatment. MVT developed in 3 (6%) pts. Two
developed MVT on prophylactic anticoagulation; one under-
went pancreaticoduodenectomy with vein resection and one
had metastatic disease at laparoscopy. The third pt received
therapeutic anticoagulation for short segment venous occlu-
sion but propagated the thrombus and was unresectable.
Thirty-nine (78%) of the 50 pts with SMV/PV narrowing/
occlusion completed all neoadjuvant therapy including resec-
tion, compared to the 21 (62%) of 34 pts with arterial only or
other BLR reason (p = 0.11).
Conclusion: MVT may develop from existing narrowing/
occlusion of SMV/PV despite prophylactic anticoagulation.
The utility of therapeutic anticoagulation requires further
assessment given the increasing application of vascular
resection/reconstruction for BLR pts.
OP-I.36 REGIONALIZATION OF
HEPATO-PANCREATO-BILIARY CANCER
TREATMENT WITHIN THE STATE OF
FLORIDA ACCORDING TO THE
AMERICAN COLLEGE OF SURGEONS
COMMISSION ON CANCER
ACCREDITATION
N. Agee1, P. Veldhuis 1, S. Eubanks1, P. Arnoletti1,2 and
S. G. De La Fuente1,2
1Florida Hospital Orlando, Orlando, FL; 2University Of
Central Florida, Orlando, FL
Background: Evidence demonstrates improved outcomes
among hepato-pancreato-biliary (HPB) cancer patients
treated at high-volume institutions. We analyzed the degree
of HPB cancer treatment regionalization within the state of
Florida using the Florida Agency for Health Care Adminis-
tration (AHCA) database.
Methods: HPB cancer patients treated at an inpatient facil-
ity were identified between April 2011 through March 2012.
Analyzed records included all patients diagnosed with HPB
malignancy within the study period (MS-DRG codes 435,
436 and 437) and associated total hospital charges. Facilities
were subsequently stratified by the American College of Sur-
geons (ACS) Commission on Cancer Accreditation (CoC),
which is based on the organization type, services provided,
and cases accessioned.
Results: 283 hospitals were identified from the database.
Treatment of HPB cancer patients was centralized to 60
institutions distributed throughout the state. Forty percent of
these facilities had an ACS Comprehensive Community
Cancer Program (CCCP) designation, while 12% were Aca-
demic Comprehensive Cancer Program (ACAD) designated,
10% were designated as an Integrated Network Cancer
Program (INCP), 3% as a National Cancer Institute Desig-
nated Comprehensive Cancer Program (NCIP), and 23%
(n = 14) had no CoC accreditation. The majority of patients
were treated at a CCCP designated program with average
total charge over two million dollars and a mean length of
stay of 6.0 days.
Conclusion: In Florida, most patients are treated at Com-
prehensive Community Cancer Programs that provide full
range of diagnostic and treatment services and participate in
cancer-related research. Based on these findings, Florida dis-
plays adequate regionalization of HPB cancer care to high
volume centers.
OP-I.37 OBESITY IS NOT ASSOCIATED
WITH PANCREATIC CARCINOMA OR
INPATIENT MORTALITY AFTER
PANCREATIC RESECTION
E. S. Glazer and E. S. Ong
The University Of Arizona, Tucson, AZ
Introduction: The interaction between obesity and pancre-
atic carcinoma (PC) is incompletely understood. The purpose
of this study was to investigate the relationship between
obesity and PC using the Nationwide Inpatient Sample
(NIS), a representative sample of patient-discharge data.
Methods: We reviewed the NIS database for years 2009–
2010 using ICD-9 diagnostic codes for PC & obesity,
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inpatient mortality, demographic data, and procedure codes.
Student’s t-test determined statistical significance (P < 0.05).
Results: 7.8% of all patients had a diagnosis of obesity
(N = 1,230,496); 0.16% had a diagnosis of PC (N = 25,585).
The average age was 63 years with 59% female. Obese
patients were more likely to be treated at teaching hospitals
than non-obese patients (48% vs. 44%, P < 0.001). Non-
obese patients had a higher rate of PC than obese patients
(0.2% vs. 0.1%, P < 0.0005). 8% of patient-discharges with
PC underwent pancreatic resection (PR). For those who died
after PR for PC, obese patients were younger than non-obese
patients (62 years vs. 71 years, P = 0.05). The mortality rate
of obese PC patients not undergoing PR was 44% lower than
for non-obese patients (P = 0.003). For PC patients undergo-
ing PR, obese patients had similar mortality rates to non-
obese patients (6% vs. 4%, P = 0.4).
Conclusion: Despite limitations in the NIS, obese patients
are diagnosed with PC at a lower rate than non-obese patients
and have lower mortality rates. There was no statistically
significant difference in inpatient mortality rates after PR for
PC based on obesity.
OP-I.38 PANCREATODUODENECTOMIES
IN COLOMBIA: A QUALITATIVE STUDY
OF THE PANCREATIC SURGERY FROM
THE SURGEONS PERSPECTIVE
J. Sabogal Olarte, C. G. Ball, F. Sutherland, O. Bathe and
E. Dixon
Hepatobiliary And Pancreatic Department. Foothills
Medical Centre – University Of Calgary, Calgary, AB
Introduction: The Whipple procedure has been histori-
cally performed by general surgeons in Colombia,
Subspecialists, have become important participants in this
field over the past 10 years however. Objectives: This quali-
tative study examines surgeons’ attitudes towards the
Whipple operation and the possibility of regionalized care
models with regards to pancreaticoduodenectomy in
Colombia. Methodology: An on-line survey was created
with 10 questions addressed to surgeons who performed
pancreatic surgery. Data was obtained from the Colombian
Association of Surgery. Individual surgeons in different
cities and hospitals around the country were contacted via
e-mail.
Results: 132 e-mails were delivered with 52 surveys being
completed (40%) by General surgeons, surgical gastroenter-
ologists, HPB surgeons and surgical oncologists. Whipples
performed per surgeon per year were less than 12 cases in
90% of participants. Self reported mortality was more 10%
in 59% of participants and 30-day morbidity was more 20%
in 63% of participants. Pancreatic surgery is performed most
commonly by general surgeons (59.52%). The majority of
participants (84.31%) believe these patients are ideally
treated in referral centres for pancreatic surgery and the
majority (75%) believe pancreatic surgery should be per-
formed by hepatobiliary surgeon.
Conclusion: Pancreatic surgery in Colombia is increasingly
common. Care of these patients in regional high volume
centers is beginning to occur. There is still significant room
for improvement with regards to peri-operative morbidity
and mortality.
OP-I.40 PANCREAS TRANSPLANTATION
OUTCOMES DIFFER BASED ON AGE
GROUPINGS: AN ANALYSIS OF THE
UNOS DATABASE
E. Siskind1, C. Maloney1, M. Akerman1, A. Shen1,
A. Basu1, E. Molmenti1 and J. Ortiz2
1North Shore Long Island Jewish Health
System-Department Of Transplantation, Manhasset, NY;
2Albert Einstein Medical Center, Philadelphia, PA
The analysis of pancreas transplantation outcomes based on
age groupings has largely been based on single center
reports. In our study, the UNOS database on all adult pan-
creas and kidney-pancreas transplant patients between 1996
and 2012 were analyzed (n = 20,854). Patients divided into
groups based on age categories: 1.18-29 (n = 1823) 2.30-39
(n = 7624) 3.40-49 (n = 7967) 4.50-59 (n = 3160) 5. ≥ 60
(n = 280) Kaplan-Meier analysis demonstrated a difference
in patient survival (p < 0.0001) and death-censored graft
survival (p < 0.0001) among the age category groups. The
following tables include 1-, 3-, 5-, 10-, and 15-year unad-
justed patient survival rates and graft survival rates for each
age category group. Patient Survival 18–29 30–39 40–49
50–59 ≥ 60 1-year 95.4% 96.0% 94.9% 93.3% 91.0%
3-year 91.3% 91.9% 90.5% 87.7% 80.2% 5-year 86.3%
87.8% 85.7% 81.6% 71.4% 10-year 73.5% 76.8% 71.8%
61.5% 42.5% 15-year 65.3% 65.6% 56.1% 41.8% 0.0%
Graft Survival 18–29 30–39 40–49 50–59 ≥ 60 1-year
80.7% 82.7% 82.9% 83.8% 82.3% 3-year 67.2% 73.3%
75.3% 74.8% 69.8% 5-year 56.8% 65.9% 67.8% 67.4%
59.9% 10-year 39.6% 48.2% 52.2% 47.5% 30.2% 15-year
26.6% 33.4% 37.2% 29.1% 0.0% Graft survival was con-
sistently the greatest in the 40–49 age group. Graft survival
was least in the 18–29 age group at 1, 3, and 5 year inter-
vals. At ten year and fifteen year intervals graft survival was
least in the age >60 group. Patient survival and age were
inversely proportional; as age increased, patient survival
decreased. This analysis differs from previous studies which
reported equivalent graft and patient survival amongst age
groups.
OP-I.42 INTERVENTIONAL RADIOLOGY
STENTING AND TPA FOR HEPATIC
ARTERY THROMBOSIS IN LIVER
TRANSPLANTATION REVISITED: A
FALSE HOPE WITH FREQUENT NEED
FOR RETRANSPLANTATION
C. W. Michalski, J. Pasko, K. Roayaie, D. L. Scott and
S. L. Orloff
Oregon Health And Science University, Portland, OR
Objective: Hepatic artery thrombosis (HAT) remains one of
the most devastating complications following orthotopic
liver transplantation (OLT). Endovascular techniques
addressing post operative HAT have recently become more
prevalent, however, there have been few reports of successful
outcomes.
Methods: We retrospectively reviewed a prospective
database for patients with HAT after OLT. All patients trans-
planted between 1992 and 2012 were analyzed. Recipients of
Donation after Cardiac Death (DCD) organs were excluded.
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Results: Within the study period, 1065 OLTs were per-
formed at our institution. Twenty patients developed HAT
(1.88%). Etiology of liver disease was PSC (5 pts), HBV (1),
HCV (5, (2-HCV/ETOH)), HBV&HCV (2), ETOH (2), and
other (5). Median time from OLT to HAT diagnosis (angiog-
raphy or CT angio) was 30 days. Six patients underwent
direct re-transplantation, 9 patients were treated with
TPA+stenting and 2 patients required no treatment (collater-
als had formed). TPA+stenting was not technically feasible in
3 patients. Re-OLT was performed in 7/9 HAT patients where
TPA+stenting was the initial therapy. Thus, in total 13/20
(65%) patients were re-transplanted. Median time to
re-transplantation was 11 months. Biliary interventions were
required in 10 patients: 7 PTC, 2 ERCP, 1 surgical revision of
choledochojejunostomy. Median survival following OLT was
94 months.
Conclusion: Failure rates for TPA+stenting for HAT are
high and eventual re-transplantation was required in the
majority of patients. These data raise the question of the
value, both in monetary cost and in morbidity to the patient,
of an interventional radiology approach in the treatment of
HAT after OLT.
OP-I.43 HPB SURGERY FROM SCRATCH:
A SINGLE SURGEON’S ONE YEAR
EXPERIENCE IN ESTABLISHING A HIGH
VOLUME HPB CENTER
J. S. Cardinal and S. Cho
West Virginia University, Morgantown, WV
Introduction: Previous reports suggest current levels of fel-
lowship training will result in an excess of hepato-pancreato-
biliary (HPB) trained surgeons by the year 2020. “High
volume” HPB centers are defined as those performing over
40 cases per year. This report describes a single surgeon’s
first year post fellowship experience in establishing a “high
volume” HPB center.
Methods: Case logs and clinic schedules were reviewed.
HPB cases were defined as those involving liver, pancreas,
gallbladder, bile duct or duodenum. Cholecystectomy was
excluded. Operative outcomes were collected and referral
patterns were tracked.
Results: From August 2012 – August 2013, 37 HPB cases
were performed (15 pancreatic, 14 hepatic, 8 other). There
were 169 new patient encounters relating to HPB problems.
For operative outcomes, average OR time was 380 min.
Average EBL was 460 mL. Eight patients received blood
transfusion(s) (range 1–8 units PRBCs). Average length of
stay was 13 days (range 2–74). 51% of patients experienced
complications, including 2 deaths which involved cases of
necrotizing pancreatitis and penetrating trauma to the porta
hepatis, respectively. Ninety-seven of the 169 (57%) patients
seen in clinic for HPB related problems were referred by
physicians from inside the health system.
Conclusion: Establishing a “high volume” HPB practice
directly out of fellowship is an achievable goal. Careful
patient selection so as to ensure excellent surgical outcomes
is the most critical aspect to practice building. Other impor-
tant tenants include capturing the majority of the in house
HPB related cases as well as robust communication with
outside referring doctors.
OP-I.44 SURGERY TO THE EXTREME:
THE CONCEPT OF TRANSPLANT
ONCOLOGY
T. Hibi, Y. Abe, O. Itano, H. Obara, M. Shinoda,
M. Kitago, H. Yagi and Y. Kitagawa
Department Of Surgery, Keio University School Of
Medicine, Tokyo, TOKYO
Introduction: Extreme cases of abdominal pathology are a
significant challenge both from the technical and tumor bio-
logical perspective. We describe 3 patients who underwent
extended resections under the principle of “no-touch isola-
tion” and by using techniques derived from liver/
multivisceral transplant and organ procurement.
Methods: Case 1: A 69-yo woman presented with massive
retroperitoneal recurrence of a liposarcoma. After creating an
axillo-femoral bypass, en-bloc resection with a Whipple pro-
cedure, concurrent right hemicolectomy and nephrectomy,
and excision of the infrarenal aorta and inferior vena cava
was performed. Case 2: A 36-yo man developed tumor
thrombi in the main portal trunk and superior mesenteric vein
after a Whipple procedure for a neuroendocrine tumor. We
established a portal bypass between the tributary of the
superior mesenteric vein and right gonadal vein. The
portomesenteric vein with tumor thrombi was excised and
reconstructed with an autologous right femoral venous graft.
Case 3: A 38-yo woman suffered ruptured renal cell carci-
noma of the left kidney with a tumor thrombus obstructing
the left renal vein. The spleen, pancreas, and left kidney were
mobilized en-bloc to avoid tumor manipulation. Extended
left nephrectomy with distal pancreatectomy and splenec-
tomy was performed without exposing the tumor capsule.
Results: Major complications included postoperative bleed-
ing and chylous ascites but no in-hospital mortalities
occurred. All patients resumed normal daily life with no
signs of recurrence during a follow-up period of 3–6 months.
Conclusion: The integration of surgical oncology and organ
transplant, “Transplant Oncology,” has opened up new hori-
zons in the field of surgery.
OP-I.45 AMPULLARY AND
EXTRA-AMPULLARY DUODENAL
ADENOCARCINOMAS HAVE
COMPARABLE SURVIVAL AFTER
POTENTIALLY CURATIVE RESECTION
K. H. Dinh, V. Bathini, B. Switzer, V. Kasturi, W. Wassef,
J. Zivny, M. Sullivan, G. Whalen and J. LaFemina
University Of Massachusetts Medical School, Worcester,
MA
Background: There is little data comparing outcomes of
ampullary and extra-ampullary duodenal adenocarcinomas.
The aim of this study is to evaluate survival and prognostic
factors of ampullary and extra-ampullary duodenal
adenocarcinomas.
Methods: Adults who underwent surgical intervention for a
duodenal adenocarcinoma from 2002–2012 were identified
from a prospectively-maintained database.
Results: Twenty-seven patients (ampullary n = 22, extra-
ampullary n = 5) had an operation for duodenal adenocarci-
noma. Twenty-six (96%) underwent potentially curative
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resection, including 21 (81%) for ampullary and 5 (19%) for
extra-ampullary. There was no significant difference in
5-year overall survival (OS), which was 70% in the entire
cohort, 72% in the ampullary group and 67% in the extra-
ampullary group (Fig. 1). Similarly, 5-year recurrence-free
survival (RFS) was not significantly different between
groups: 56%, 52% and 75% respectively. There was no dif-
ference in gender (p = 1.00), age at diagnosis (p = 0.62),
number of lymph nodes harvested (p = 0.54), or margin
status (R0 resection, 100%). Tumor size (OS: p = 0.60; RFS:
p = 0.64), stage (p = 0.16; p = 0.91), and presence of positive
nodes (p = 0.67; p = 0.53) were not associated with OS or
RFS. Chemotherapy (p = 0.62) was not associated with OS.
Conclusion: Ampullary and extra-ampullary duodenal
adenocarcinomas have similar overall survival and
recurrence-free survival following potentially curative surgi-
cal resection.
OP-I.46 TIPS IS NOT NECESSARY FOR
THE SUCCESSFUL MANAGEMENT OF
RUPTURED PARAUMBILICAL HERNIAS
IN PATIENTS WITH ADVANCED
HEPATIC CIRRHOSIS AND
REFRACTORY ASCITES
N. A. Chatzizacharias, J. A. Bradley, E. Huguet, A. Jah,
N. V. Jamieson, R. K. Praseedom and P. Gibbs
Department Of HPB And Transplant Surgery,
Addenbrooke’s University Hospital, Cambridge, UK,
Cambridge, CAMBRIDGESHIRE
Introduction: Acute umbilical hernia rupture in patients
with hepatic cirrhosis and ascites is an unusual, but poten-
tially life-threatening complication. The postoperative mor-
bidity has been evaluated as high as 71%, with mortality rates
varying between 60–80% after supportive care and 6–20%
after urgent surgical repair. Management options include
primary surgical repair with or without concomitant portal
venous system decompression. Recently, the routine use of
transjugular intrahepatic portosystemic shunting (TIPS) in
the preoperative setting resulted in improved perioperative
and longer-term results. We present our centre’s experience
in this area.
Results: Eleven patients (mean age: 52,5 years, range:
36–63 years) with advanced hepatic cirrhosis (Childs B and
C) and refractory ascites were treated in our institution for
ruptured paraumbilical hernias over a 6-year period. Appro-
priate patient resuscitation and optimisation with intravenous
fluids, prophylactic antibiotics and local measures, such as
non occlusive dressings, was instituted. One failed attempt
for conservative management was followed by a successful
primary repair. In all cases a primary repair with non-
absorbable Nylon, interrupted sutures was performed. No
mesh was used. The perioperative complication rate was 25%
and the recurrence rate 8.3%. No mortality was recorded.
Mean length of hospital stay was 15.5 days (range: 4–31
days).
Conclusion: Based on our experience, the management of
ruptured paraumbilical hernias in patients with advanced
hepatic cirrhosis and refractory ascites is feasible without the
use of TIPS routinely in the preoperative period, provided
that meticulous patient optimisation is performed.
OP-I.47 A MULTI-DETECTOR CT
ANALYSIS OF THE ABDOMINAL WALL
STRUCTURE AROUND THE UMBILICUS
WITH SPECIAL REFERENCE TO THE
DEHISCENCE OF THE LINEA ALBA:
COULD IT BE AN UNDER-RECOGNIZED
PREDISPOSING FACTOR FOR ADULT
UMBILICAL HERNIA?
A. Shimizu1,2, U. Mitsuhashi1, M. Tanaka1 and Y. Yasuda2
1Koganei Central Hospital, Shimotsuke, TOCHIGI; 2Jichi
Medical University, Shimotsuke, TOCHIGI
Introduction: Most adult umbilical hernias that
hepatobiliary and general surgeons treat are attributed to
ascites, obesity and multi-parity. Patients without these
factors, however, occasionally present with this condition.
Therefore other cause must be sought. To date little is inves-
tigated about the radiological anatomy of the umbilical struc-
tures. Purpose: The aim of this study is to address the
incidence of the linea alba dehiscence at the umbilicus using
multi-detector computed tomography (CT) and explore its
relation to the patients’ habitus and body fat composite.
Methods: One hundred and forty eight abdominal CT scans
performed in our institution between June and August 2013
from patients without history of previous surgery around the
umbilicus were analyzed. Multi-planar reconstruction was
performed to evaluate the abdominal wall. CT scan cuts at the
level of the umbilicus were used to calculate the total fat area
(TFA), visceral fat area (VFA), subcutaneous fat area (SFA)
by fat measurement soft ware (Toshiba).
Results: Opening of the fascial structure at the umbilicus
was noted in 25% (37 out of 148) of the patients although
none of them demonstrated umbilical hernia clinically. Open
group are younger, showed statistically larger BMI, abdomi-
nal girth, TFA, and VFA than closed group (p < 0.05). (table)
Conclusion: Occult dehiscence of the linea alba is often
radiologically appreciated in adult population but the
opening per se does not lead to the development of the
umbilical hernia. Visceral fat accumulation may play a role
in the increase in intra-abdominal pressure and diastasis of
the fascia.
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FRIDAY, FEBRUARY 21, 2014,
6:30PM–7:15PM
RECEPTION VIDEO
PRESENTATIONS
VR.01 LAPAROSCOPIC REPAIR OF ERCP
RELATED DUODENAL PERFORATION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, J. J. Lewis,
D. Sindram, J. B. Martinie and D. A. Iannitti
Carolinas Medical Center, Charlotte, NC
ERCP is a common procedure with a 0.3–2.0% risk of duo-
denal perforation. Free perforation into the abdominal cavity
(Type I perforation) has a higher mortality risk and requires
surgical intervention. Traditionally this is performed by lapa-
rotomy. This video demonstrates a laparoscopic repair of a
Type I ERCP-related duodenal perforation. The patient is an
84 year old female with nausea and elevated liver enzymes
who was found on MRCP to have a dilated bile duct and on
EUS to have sludge in the distal bile without associated mass.
On ERCP she was found to have ampullary stenosis and
sludge in the bile duct. An endoscopic sphincterotomy was
performed. Immediately post-procedure she developed
abdominal distention and pain. Free air was confirmed on
abdominal X-ray. She was taken to the OR for laparoscopic
repair with intra-operative EGD. Bile was aspirated from the
upper abdomen and the abdomen was irrigated. A 2 cm pos-
terior perforation was identified on the second portion of the
duodenum by endoscopic insufflation of the duodenum under
saline submersion. The duodenum was mobilized and the
perforation was closed with interrupted PDS sutures. A round
ligament flap and fibrin glue was used to reinforce the
closure. The patient did well and was discharged home on
post-operative day three. This video demonstrates that
laparoscopic repair of an ERCP-related type I duodenal per-
foration is an effective alternative to open laparotomy.
VR.02 KLATSKIN TUMOR: LEFT
HEPATECTOMY WITH CAUDATE LOBE
RESECTION USING LEFT HANGING
MANEUVER
R. Sanchez Clariá, N. Resio, O. Mazza, F. Alvarez,
M. de Santibañes and S. Bilbao
Hospital Italiano Buenos Aires, Capital Federal, BUENOS
AIRES
carcinoma ohf the hepatic duct confluence is the most common
site of bile duct malignancies significant progress has been made
in recent years in the diagnosis and treatment of this disease the
video show a left hepatectomy with caudate lobe resection did
it in a healthy 46 years old woman a left hanging maneuver
was used and make transection more easy and faster combined
liver and bile duct resection can be performed for hiliar
cholangiocarcinoma with acceptable mortality hanging manuver
it is useful for right and for left liver resection.
VR.03 ROBOTIC ASSISTED CYST
GASTROSTOMY AND EXCISION OF A
PANCREATIC PSEUDOCYST
EXTENDING TO THE PELVIS
T. K. Nguyen and A. H. Zureikat
University Of Pittsburgh Department Of Surgery,
Pittsburgh, PA
Introduction: Pancreatic pseudocysts can be a debilitating
sequelae of pancreatitis. Many pseudocysts can be managed con-
servatively with observation or with percutaneous or endoscopic
drainage. Rarely, do pseudocysts enlarge despite conservative
measures to extend to the pelvis. In this video, we present a
minimally invasive surgery approach for management of an
extraordinarily large pseudocyst in a patient with chronic pan-
creatitis secondary to systemic lupus erythematosus.
Methods: A cyst gastrostomy, pancreatic debridement, and
excision of a pelvic pseudocyst were performed using a
robotic assisted and laparoscopic technique.
Results/Conclusion: A robotic assisted approach for the
surgical management of a symptomatic pseudocyst is still
feasible even with extension to the pelvis.
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LO-D.01 SPLENOPNEUMOPEXY:
DECOMPRESSION OF PORTAL
HYPERTENSION IN THE SETTING OF
PORTAL VENOUS OCCLUSIVE DISEASE
J. M. Sutton, S. L. Starnes and S. A. Shah
Department Of Surgery, University Of Cincinnati Medical
Center, Cincinnati, OH
Background: Portal venous hypertension due to complete
occlusion of the portal, splenic, and superior mesenteric
veins may result in significant life-threatening bleeding from
ruptured esophagogastric varices. Decompression options,
such as transjugular intrahepatic portosystemic shunt (TIPS),
surgical shunts, or the Sigiura procedure, are limited due to
lack of venous flow. Splenopneumopexy provides an alter-
native decompressive procedure resulting in decompression
through the splenic pulp into the pulmonary venous system
and then the right atrium.
Methods: We describe two patients who have recently
undergone splenopneumopexy (video presentation). The day
prior to surgery, splenic artery embolization is performed by
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